Exercise Echocardiography in Hypertrophic Cardiomyopathy

Jesus Peteiro

Publication date

October 2014

DOI

Abstract

Hypertrophic cardiomyopathy (HCM) is a relatively frequent genetic disease that affects 1/500 human beings. Main problems with this disease are the development of symptoms in 10-20% of affected individuals, and the increased risk of sudden cardiac death (SCD) in a subset of patients with the disease. It is important to clarify the cause of symptoms and to assess the risk of sudden death in HCM because we do have therapies to relief these problems

Extracted data

We use cookies to provide a better user experience.

Data Protection

Exercise Echocardiography in Hypertrophic Cardiomyopathy

Jesus Peteiro

Open link

Publication date

October 2014

DOI

10.17352/2455-2976.000009

Abstract

Extracted data

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers:determining the best cardiological screening strategy

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Exercise Echocardiography in Hypertrophic Cardiomyopathy

Jesus Peteiro
Alberto Bouzas-Mosquera

October 2014

Hypertrophic cardiomyopathy (HCM) is a relatively frequent genetic disease that affects 1/500 human ...

Hypertrophic Cardiomyopathy: Challenging the Status Quo?

Younger, John
Lo, Ada
McCormack, Louise
McGaughran, Julie
Prasad, Sandhir
Atherton, John J.

April 2020

Hypertrophic cardiomyopathy (HCM) is the most common cardiovascular genetic disorder. While our mech...

Hypertrophic cardiomyopathy: state of the art in 2007

Monteiro, S
Costa, S
Monteiro, P
Gonçalves, L
Providência, LA

January 2008

Hypertrophic cardiomyopathy (HCM) is a primary disease of the sarcomere, with considerable genetic h...

Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy

Kramer, C.M.
Appelbaum, E.
Desai, M.Y.
Desvigne-Nickens, P.
DiMarco, J.P.
Friedrich, M.G.
Geller, N.
Heckler, S.
Ho, C.Y.
Jerosch-Herold, M.
Ivey, E.A.
Keleti, J.
Kim, D.Y.
Kolm, P.
Kwong, R.Y.
Maron, M.S.
Schulz-Menger, J.
Piechnik, S.
Watkins, H.
Weintraub, W.S.
Wu, P.
Neubauer, S.

August 2015

Hypertrophic cardiomyopathy (HCM) is the most common monogenic heart disease with a frequency as hig...

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers:determining the best cardiological screening strategy

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy

Kramer, C.M.
Appelbaum, E.
Desai, M.Y.
Desvigne-Nickens, P.
DiMarco, J.P.
Friedrich, M.G.
Geller, N.
Heckler, S.
Ho, C.Y.
Jerosch-Herold, M.
Ivey, E.A.
Keleti, J.
Kim, D.Y.
Kolm, P.
Kwong, R.Y.
Maron, M.S.
Schulz-Menger, J.
Piechnik, S.
Watkins, H.
Weintraub, W.S.
Wu, P.
Neubauer, S.

August 2015

Hypertrophic cardiomyopathy (HCM) is the most common monogenic heart disease with a frequency as hig...

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers:determining the best cardiological screening strategy

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Related items

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers:determining the best cardiological screening strategy

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Exercise Echocardiography in Hypertrophic Cardiomyopathy

Jesus Peteiro
Alberto Bouzas-Mosquera

October 2014

Hypertrophic cardiomyopathy (HCM) is a relatively frequent genetic disease that affects 1/500 human ...

Hypertrophic Cardiomyopathy: Challenging the Status Quo?

Younger, John
Lo, Ada
McCormack, Louise
McGaughran, Julie
Prasad, Sandhir
Atherton, John J.

April 2020

Hypertrophic cardiomyopathy (HCM) is the most common cardiovascular genetic disorder. While our mech...

Hypertrophic cardiomyopathy: state of the art in 2007

Monteiro, S
Costa, S
Monteiro, P
Gonçalves, L
Providência, LA

January 2008

Hypertrophic cardiomyopathy (HCM) is a primary disease of the sarcomere, with considerable genetic h...

Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy

Kramer, C.M.
Appelbaum, E.
Desai, M.Y.
Desvigne-Nickens, P.
DiMarco, J.P.
Friedrich, M.G.
Geller, N.
Heckler, S.
Ho, C.Y.
Jerosch-Herold, M.
Ivey, E.A.
Keleti, J.
Kim, D.Y.
Kolm, P.
Kwong, R.Y.
Maron, M.S.
Schulz-Menger, J.
Piechnik, S.
Watkins, H.
Weintraub, W.S.
Wu, P.
Neubauer, S.

August 2015

Hypertrophic cardiomyopathy (HCM) is the most common monogenic heart disease with a frequency as hig...

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers:determining the best cardiological screening strategy

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy

Kramer, C.M.
Appelbaum, E.
Desai, M.Y.
Desvigne-Nickens, P.
DiMarco, J.P.
Friedrich, M.G.
Geller, N.
Heckler, S.
Ho, C.Y.
Jerosch-Herold, M.
Ivey, E.A.
Keleti, J.
Kim, D.Y.
Kolm, P.
Kwong, R.Y.
Maron, M.S.
Schulz-Menger, J.
Piechnik, S.
Watkins, H.
Weintraub, W.S.
Wu, P.
Neubauer, S.

August 2015

Hypertrophic cardiomyopathy (HCM) is the most common monogenic heart disease with a frequency as hig...

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers:determining the best cardiological screening strategy

Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Mannens, Marcel M. A. M.
Michels, Michelle
Majoor-Krakauer, Danielle
Dooijes, Dennis
van Tintelen, J. Peter
van den Berg, Maarten P.
Volders, Paul G. A.
Arens, Yvonne H.
van den Wijngaard, Arthur
Atsma, Douwe E.
Helderman-van den Enden, Apollonia T. J. M.
Houweling, Arjan C.
de Boer, Karin
van der Smagt, Jasper J.
Hauer, Richard N. W.
Marcelis, Carlo L. M.
Timmermans, Janneke
van Langen, Irene M.
Wilde, Arthur A. M.

May 2011

Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...